Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine anterior quadratus lumborum block in laparoscopic gynecologic surgery
ChiCTR2500096893Phase 4Not yet recruiting
- Sponsor
- Wuxi Xishan People's Hospital
- Start
- Feb 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Wuxi Xishan People's Hospital. Primary endpoint: Oxycodone consumption during first 48 hours postoperatively. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500096893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096893.